How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Close this folder3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
View the documentDeveloping locally relevant introductory information
Open this folder and view contentsGeneral entries at the front of a national formulary
Open this folder and view contentsAdditional information at the front of the national formulary
View the documentAdapting the “General advice to prescribers” section of the WHO model formulary
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Developing locally relevant introductory information

The intended purpose, audience and ease of use should be kept in focus when compiling information for the preliminary section of the NF. Overloading the front of the NF with numerous copies of local documents may increase the volume and the production costs of the NF, without offering much helpful and practical information to the user.

The preliminary section of a formulary usually contains the following sections and can include additional information, as listed below. Please note that the ordering of this list does not necessarily reflect the ideal order of entries in a NF.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014